200 related articles for article (PubMed ID: 35402292)
1. Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves' Disease Before and After Methimazole Treatment.
Yang M; Zheng X; Wu Y; Zhang R; Yang Q; Yu Z; Liu J; Zha B; Gong Q; Yang B; Sun B; Zeng M
Front Cell Infect Microbiol; 2022; 12():794711. PubMed ID: 35402292
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the Intestinal Microbial Flora and the Serum IL-17 Level in Patients with Graves' Disease Complicated with Vitamin D Deficiency.
Yang M; Li F; Zhang R; Wu Y; Yang Q; Wang F; Yu Z; Liu J; Cha B; Gong Q; Yang B; Sun B; Ding H
Int Arch Allergy Immunol; 2022; 183(2):225-234. PubMed ID: 34544076
[TBL] [Abstract][Full Text] [Related]
3. Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease.
Chen J; Wang W; Guo Z; Huang S; Lei H; Zang P; Lu B; Shao J; Gu P
J Endocrinol Invest; 2021 Sep; 44(9):1913-1926. PubMed ID: 33481211
[TBL] [Abstract][Full Text] [Related]
4. Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid.
Su X; Yin X; Liu Y; Yan X; Zhang S; Wang X; Lin Z; Zhou X; Gao J; Wang Z; Zhang Q
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785703
[TBL] [Abstract][Full Text] [Related]
5. A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease.
Xu B; Wu D; Ying H; Zhang Y
Turk J Med Sci; 2019 Jun; 49(3):715-722. PubMed ID: 31023005
[TBL] [Abstract][Full Text] [Related]
6. The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome.
Han Z; Cen C; Ou Q; Pan Y; Zhang J; Huo D; Chen K
Front Immunol; 2021; 12():826067. PubMed ID: 35082799
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole.
Liu K; Fu Y; Li T; Liu S; Chen D; Zhao C; Shi Y; Cai Y; Yang T; Zheng X
Clin Biochem; 2021 Nov; 97():34-40. PubMed ID: 34331946
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microbiota changes in Graves' disease: a prospective clinical study.
Yan HX; An WC; Chen F; An B; Pan Y; Jin J; Xia XP; Cui ZJ; Jiang L; Zhou SJ; Jin HX; Ou XH; Huang W; Hong TP; Lyu ZH
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32820337
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the intestinal flora may participate in the development of Graves' disease: a study conducted among the Han population in southwest China.
Yang M; Sun B; Li J; Yang B; Xu J; Zhou X; Yu J; Zhang X; Zhang Q; Zhou S; Sun X
Endocr Connect; 2019 Jul; 8(7):822-828. PubMed ID: 31137015
[TBL] [Abstract][Full Text] [Related]
10. Probiotic Bifidobacterium longum supplied with methimazole improved the thyroid function of Graves' disease patients through the gut-thyroid axis.
Huo D; Cen C; Chang H; Ou Q; Jiang S; Pan Y; Chen K; Zhang J
Commun Biol; 2021 Sep; 4(1):1046. PubMed ID: 34493790
[TBL] [Abstract][Full Text] [Related]
11. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
[TBL] [Abstract][Full Text] [Related]
12. Alterations and Mechanism of Gut Microbiota in Graves' Disease and Hashimoto's Thyroiditis.
Zhao H; Yuan L; Zhu D; Sun B; Du J; Wang J
Pol J Microbiol; 2022 Jun; 71(2):173-189. PubMed ID: 35675824
[TBL] [Abstract][Full Text] [Related]
13. Serum thyroglobulin is associated with orbitopathy in Graves' disease.
Khamisi S; Lundqvist M; Emadi P; Almby K; Ljunggren Ö; Karlsson FA
J Endocrinol Invest; 2021 Sep; 44(9):1905-1911. PubMed ID: 33515213
[TBL] [Abstract][Full Text] [Related]
14. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves' Disease.
Jiang W; Yu X; Kosik RO; Song Y; Qiao T; Tong J; Liu S; Fan S; Luo Q; Chai L; Lv Z; Li D
Thyroid; 2021 May; 31(5):810-820. PubMed ID: 33234057
[No Abstract] [Full Text] [Related]
16. Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy.
Choi YM; Kwak MK; Hong SM; Hong EG
Endocrinol Metab (Seoul); 2019 Sep; 34(3):268-274. PubMed ID: 31565879
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?
Zingrillo M; D'Aloiso L; Ghiggi MR; Di Cerbo A; Chiodini I; Torlontano M; Liuzzi A
Clin Endocrinol (Oxf); 1996 Aug; 45(2):201-6. PubMed ID: 8881453
[TBL] [Abstract][Full Text] [Related]
18. Molecular Alteration Analysis of Human Gut Microbial Composition in Graves' disease Patients.
Ishaq HM; Mohammad IS; Shahzad M; Ma C; Raza MA; Wu X; Guo H; Shi P; Xu J
Int J Biol Sci; 2018; 14(11):1558-1570. PubMed ID: 30263008
[TBL] [Abstract][Full Text] [Related]
19. Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease.
Leite AC; Pedro AB; Romaldini JH
Horm Metab Res; 2011 Mar; 43(3):194-9. PubMed ID: 21283953
[TBL] [Abstract][Full Text] [Related]
20. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
